Immune checkpoint inhibitors (ICIs) have revolutionized oncology by enhancing the immune system’s ability to target tumours, leading to significant cancer regression. Key ICIs include nivolumab...
Urgent care centres are medical clinics that provide same-day, urgent treatment for non–life-threatening illnesses or injuries, such as infections, sprains, earaches, broken bones, and fevers. These...
Major neurocognitive disorder (MNCD), previously called dementia, includes diseases like Alzheimer disease. MNCD prevalence is low in those younger than aged 65 years but rises sharply with age. MNCD...
Canada's opioid overdose crisis has led to increased deaths and hospitalizations due to potent illicit opioids like fentanyl. In response, harm reduction strategies, including safer supply programs...
Review Type: Rapid Provisional Funding Algorithm Scope posting: Jan 23, 2025 Stakeholder Input Deadline: Mar 18, 2025 Draft Report Posted (Target): July 31, 2025 Stakeholder Feedback Deadline (Target)...
Influenza is an acute viral respiratory infection that can cause significant morbidity and mortality. In Canada, 4 antiviral drugs are available to treat influenza. Early treatment has been shown to...
Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and...
Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and...
The objectives of the query are to describe the following from the years 2017 to 2024: the incidence and prevalence of long-acting injectable (LAI) antipsychotics in Canada and by province; the...
Immune checkpoint inhibitors (ICIs), such as pembrolizumab and cemiplimab, are approved for various cancers. Both are typically administered for up to 2 years, with evidence supporting re-treatment...